Publications by authors named "David J McCann"

14Publications

Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.

J Clin Pharmacol 2019 08 12;59(8):1078-1084. Epub 2019 Mar 12.

National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606390PMC
August 2019

Linear-rank testing of a non-binary, responder-analysis, efficacy score to evaluate pharmacotherapies for substance use disorders.

Stat Methods Med Res 2018 07 25;27(7):2154-2167. Epub 2016 Nov 25.

2 Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse (NIDA), National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0962280216677317DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690342PMC
July 2018

Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.

Drug Alcohol Depend 2016 Sep 28;166:13-20. Epub 2016 May 28.

Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2016.05.019DOI Listing
September 2016

Mitigating the Effects of Nonadherence in Clinical Trials.

J Clin Pharmacol 2016 09 22;56(9):1151-64. Epub 2016 Jan 22.

Pharmaceutical Product Development, LLC, Wilmington, NC, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcph.689
Publisher Site
http://dx.doi.org/10.1002/jcph.689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066799PMC
September 2016

Deception by Research Participants.

N Engl J Med 2015 Sep;373(13):1192-3

From the National Institute of Environmental Health Sciences (D.B.R.) and the National Institute on Drug Abuse (D.J.M.), National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1506985DOI Listing
September 2015

Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development.

J Clin Psychopharmacol 2015 Oct;35(5):566-73

From the *Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, NIH, Bethesda, MD; †Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT; and ‡Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553101PMC
October 2015

Trends in opioid analgesic abuse and mortality in the United States.

N Engl J Med 2015 04;372(16):1572-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1501822DOI Listing
April 2015

A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial.

CNS Neurosci Ther 2012 May 18;18(5):414-8. Epub 2011 Oct 18.

Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-5949.2011.00263.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493362PMC
May 2012

Drugs of abuse: management of intoxication and antidotes.

EXS 2010 ;100:519-41

Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-7643-8338-1_15DOI Listing
April 2010

Summary of NIDA medications workshop: new opportunities for chemists and pharmacologists.

Drug Alcohol Depend 2008 Jan;92(1-3):307-11

Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institute of Health, Bethesda, MD 20892-9551, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2007.05.020DOI Listing
January 2008

Rash and fever.

J Emerg Med 2006 Oct;31(3):293-7

Division of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2006.07.001DOI Listing
October 2006

Sixth cranial nerve palsy.

J Emerg Med 2005 Aug;29(2):207-11

Division of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2005.04.006DOI Listing
August 2005